Works by Mahadevan, Daruka
Results: 52
Phase 2 Open-Label Study of Bortezomib, Cladribine, and Rituximab in Advanced, Newly Diagnosed, and Relapsed/Refractory Mantle-Cell and Indolent Lymphomas.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Modulation of Ligand binding by alternative splicing of the αPS2 integrin subunit.
- Published in:
- Journal of Cellular Biochemistry, 2007, v. 102, n. 1, p. 211, doi. 10.1002/jcb.21288
- By:
- Publication type:
- Article
An Analog of Withaferin A Activates the MAPK and Glutathione 'Stress' Pathways and Inhibits Pancreatic Cancer Cell Proliferation.
- Published in:
- Cancer Investigation, 2011, v. 29, n. 10, p. 668, doi. 10.3109/07357907.2011.626478
- By:
- Publication type:
- Article
Carcinoembryonic antigen cell adhesion molecule 6 (CEACAM6) in Pancreatic Ductal Adenocarcinoma (PDA): An integrative analysis of a novel therapeutic target.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-54545-9
- By:
- Publication type:
- Article
A call to arms: Unifying the fight against resistance.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
DNA methylation biomarkers discovered in silico detect cancer in liquid biopsies from non-small cell lung cancer patients.
- Published in:
- Epigenetics, 2020, v. 15, n. 4, p. 419, doi. 10.1080/15592294.2019.1695333
- By:
- Publication type:
- Article
A phase 1/2 trial of ublituximab, a novel anti- CD20 monoclonal antibody, in patients with B-cell non-Hodgkin lymphoma or chronic lymphocytic leukaemia previously exposed to rituximab.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 2, p. 243, doi. 10.1111/bjh.14534
- By:
- Publication type:
- Article
Ublituximab ( TG-1101), a novel glycoengineered anti- CD20 antibody, in combination with ibrutinib is safe and highly active in patients with relapsed and/or refractory chronic lymphocytic leukaemia: results of a phase 2 trial.
- Published in:
- British Journal of Haematology, 2017, v. 176, n. 3, p. 412, doi. 10.1111/bjh.14447
- By:
- Publication type:
- Article
Yttrium-90-Ibritumomab Tiuxetan (Zevalin®) Radioimmunotherapy after Cytoreduction with ESHAP Chemotherapy in Patients with Relapsed Follicular Non-Hodgkin Lymphoma: Final Results of a Phase II Study.
- Published in:
- Oncology, 2018, v. 94, n. 5, p. 274, doi. 10.1159/000486788
- By:
- Publication type:
- Article
Dispositional optimism and therapeutic expectations in early-phase oncology trials.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Phase 2 trial of combined cisplatin, etoposide, gemcitabine, and methylprednisolone (PEGS) in peripheral T-cell non-Hodgkin lymphoma: Southwest Oncology Group Study S0350.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Phase 2 trial of combined cisplatin, etoposide, gemcitabine, and methylprednisolone (PEGS) in peripheral T-cell non-Hodgkin lymphoma.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 2, p. 371, doi. 10.1002/cncr.27733
- By:
- Publication type:
- Article
A phase 2 randomized multicenter study of 2 extended dosing schedules of oral ezatiostat in low to intermediate-1 risk myelodysplastic syndrome.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 8, p. 2138, doi. 10.1002/cncr.26469
- By:
- Publication type:
- Article
ERBB2 (HER2) amplifications and co-occurring KRAS alterations in the circulating cell-free DNA of pancreatic ductal adenocarcinoma patients and response to HER2 inhibition.
- Published in:
- Frontiers in Oncology, 2024, p. 01, doi. 10.3389/fonc.2024.1339302
- By:
- Publication type:
- Article
RTHP-09. DYSREGULATION OF Wnt SIGNALING PATHWAY CORRELATES WITH TREATMENT OUTCOME IN GLIOBLASTOMA MULTIFORME.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi227, doi. 10.1093/neuonc/noy148.941
- By:
- Publication type:
- Article
Phase I trial of UNBS5162, a novel naphthalimide in patients with advanced solid tumors or lymphoma.
- Published in:
- International Journal of Clinical Oncology, 2013, v. 18, n. 5, p. 934, doi. 10.1007/s10147-012-0475-8
- By:
- Publication type:
- Article
Transcriptosome and serum cytokine profiling of an atypical case of myelodysplastic syndrome with progression to acute myelogenous leukemia.
- Published in:
- American Journal of Hematology, 2006, v. 81, n. 10, p. 779, doi. 10.1002/ajh.20690
- By:
- Publication type:
- Article
Variations in Unrealistic Optimism Between Acceptors and Decliners of Early Phase Cancer Trials.
- Published in:
- Journal of Empirical Research on Human Research Ethics, 2017, v. 12, n. 4, p. 280, doi. 10.1177/1556264617720433
- By:
- Publication type:
- Article
Gene Expression Patterns Associated with Survival in Glioblastoma.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 7, p. 3668, doi. 10.3390/ijms25073668
- By:
- Publication type:
- Article
Using cfDNA and ctDNA as Oncologic Markers: A Path to Clinical Validation.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 17, p. 13219, doi. 10.3390/ijms241713219
- By:
- Publication type:
- Article
MP470, a novel receptor tyrosine kinase inhibitor, in combination with Erlotinib inhibits the HER family/PI3K/Akt pathway and tumor growth in prostate cancer.
- Published in:
- BMC Cancer, 2009, v. 9, p. 1, doi. 10.1186/1471-2407-9-142
- By:
- Publication type:
- Article
AT9283, a novel aurora kinase inhibitor, suppresses tumor growth in aggressive B-cell lymphomas.
- Published in:
- International Journal of Cancer, 2012, v. 130, n. 12, p. 2997, doi. 10.1002/ijc.26324
- By:
- Publication type:
- Article
Final results of a multicenter phase 1 study of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia.
- Published in:
- Leukemia & Lymphoma, 2012, v. 53, n. 3, p. 417, doi. 10.3109/10428194.2011.618232
- By:
- Publication type:
- Article
Pharmacotherapeutic options for pancreatic ductal adenocarcinoma.
- Published in:
- Expert Opinion on Pharmacotherapy, 2022, v. 23, n. 18, p. 2079, doi. 10.1080/14656566.2022.2149322
- By:
- Publication type:
- Article
The Impact of Unrealistic Optimism on Informed Consent in Early-Phase Oncology Trials.
- Published in:
- IRB: Ethics & Human Research, 2016, v. 38, n. 5, p. 1
- By:
- Publication type:
- Article
Real-world data of off-label drug use in patients with actionable genomic alterations on next-generation sequencing.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 3, p. 643, doi. 10.1007/s10637-022-01213-x
- By:
- Publication type:
- Article
A multicenter phase 1/2 study investigating the safety, pharmacokinetics, pharmacodynamics and efficacy of a small molecule antimetabolite, RX-3117, plus nab-paclitaxel in pancreatic adenocarcinoma.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 1, p. 81, doi. 10.1007/s10637-021-01164-9
- By:
- Publication type:
- Article
A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 6, p. 1060, doi. 10.1007/s10637-018-0625-6
- By:
- Publication type:
- Article
Correction to: Phase II study of bi-weekly temozolomide plus bevacizumab for adult patients with recurrent glioblastoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase II study of bi-weekly temozolomide plus bevacizumab for adult patients with recurrent glioblastoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase 1b study of safety, tolerability and efficacy of R1507, a monoclonal antibody to IGF-1R in combination with multiple standard oncology regimens in patients with advanced solid malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 3, p. 467, doi. 10.1007/s00280-013-2372-x
- By:
- Publication type:
- Article
An integrin-targeted, pan-isoform, phosphoinositide-3 kinase inhibitor, SF1126, has activity against multiple myeloma in vivo.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 867, doi. 10.1007/s00280-013-2078-0
- By:
- Publication type:
- Article
Phase I Trial of Cemiplimab, Radiotherapy, Cyclophosphamide, and Granulocyte Macrophage Colony‐Stimulating Factor in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. e1508, doi. 10.1002/onco.13810
- By:
- Publication type:
- Article
Academic Cancer Center Phase I Program Development.
- Published in:
- Oncologist, 2017, v. 22, n. 4, p. 369, doi. 10.1634/theoncologist.2016-0409
- By:
- Publication type:
- Article
A Novel Triplet of Alisertib Plus Ibrutinib Plus Rituximab Is Active in Mantle Cell Lymphoma.
- Published in:
- Cancers, 2024, v. 16, n. 24, p. 4257, doi. 10.3390/cancers16244257
- By:
- Publication type:
- Article
Expression Levels of RAD51 Inversely Correlate with Survival of Glioblastoma Patients.
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5358, doi. 10.3390/cancers13215358
- By:
- Publication type:
- Article
Clinical Predictors of Early Trial Discontinuation for Patients Participating in Phase I Clinical Trials in Oncology.
- Published in:
- Cancers, 2021, v. 13, n. 10, p. 2304, doi. 10.3390/cancers13102304
- By:
- Publication type:
- Article
BTLA/HVEM Axis Induces NK Cell Immunosuppression and Poor Outcome in Chronic Lymphocytic Leukemia.
- Published in:
- Cancers, 2021, v. 13, n. 8, p. 1766, doi. 10.3390/cancers13081766
- By:
- Publication type:
- Article
Cross-Resistance to Abiraterone and Enzalutamide in Castration Resistance Prostate Cancer Cellular Models Is Mediated by AR Transcriptional Reactivation.
- Published in:
- Cancers, 2021, v. 13, n. 6, p. 1483, doi. 10.3390/cancers13061483
- By:
- Publication type:
- Article
The Identity of PDGFRA D842V-Mutant Gastrointestinal Stromal Tumors (GIST).
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 705, doi. 10.3390/cancers13040705
- By:
- Publication type:
- Article
TP53 Mutations as a Driver of Metastasis Signaling in Advanced Cancer Patients.
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 597, doi. 10.3390/cancers13040597
- By:
- Publication type:
- Article
Rare Tumor-Normal Matched Whole Exome Sequencing Identifies Novel Genomic Pathogenic Germline and Somatic Aberrations.
- Published in:
- Cancers, 2020, v. 12, n. 6, p. 1618, doi. 10.3390/cancers12061618
- By:
- Publication type:
- Article
A Comparative Analysis of Tumors and Plasma Circulating Tumor DNA in 145 Advanced Cancer Patients Annotated by 3 Core Cellular Processes.
- Published in:
- Cancers, 2020, v. 12, n. 3, p. 701, doi. 10.3390/cancers12030701
- By:
- Publication type:
- Article
PD-1-Associated Gene Expression Signature of Neoadjuvant Trastuzumab-Treated Tumors Correlates with Patient Survival in HER2-Positive Breast Cancer.
- Published in:
- Cancers, 2019, v. 11, n. 10, p. 1566, doi. 10.3390/cancers11101566
- By:
- Publication type:
- Article
Gene Expression and Serum Cytokine Profiling of Low Stage CLL Identify WNT/PCP, Flt-3L/Flt-3, and CXCL9/CXCR3 as Regulators of Cell Proliferation, Survival, and Migration.
- Published in:
- Human Genomics & Proteomics, 2009, v. 2009, p. 1, doi. 10.4061/2009/453634
- By:
- Publication type:
- Article
Mapping of the active site of glutamate carboxypeptidase II by site-directed mutagenesis.
- Published in:
- FEBS Journal, 2007, v. 274, n. 18, p. 4731, doi. 10.1111/j.1742-4658.2007.06021.x
- By:
- Publication type:
- Article
The extracellular regions of PSMA and the transferrin receptor contain an aminopeptidase domain: Implications for drug design.
- Published in:
- Protein Science: A Publication of the Protein Society, 1999, v. 8, n. 11, p. 2546, doi. 10.1110/ps.8.11.2546
- By:
- Publication type:
- Article
Identification of a Frizzled-like cysteine rich domain in the extracellular region of developmental receptor tyrosine kinases
- Published in:
- Protein Science: A Publication of the Protein Society, 1998, v. 7, n. 7, p. 2632
- By:
- Publication type:
- Article
CTL recognition of a novel HLA-A*0201-binding peptide derived from glioblastoma multiforme tumor cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 9, p. 1319, doi. 10.1007/s00262-011-1032-4
- By:
- Publication type:
- Article
Clinical trials targeting neurofibromatoses-associated tumors: a systematic review.
- Published in:
- Neuro-Oncology Advances, 2022, v. 4, n. 1, p. 1, doi. 10.1093/noajnl/vdac005
- By:
- Publication type:
- Article